Belvedere Trading LLC Cel Sci Corp Transaction History

Belvedere Trading LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 25, 2022	SELL	$7.1 - $12.82 $74,024 - $133,661	-10,426 Closed	0 $0
Q3 2021 Oct 19, 2021	SELL	$7.64 - $12.49 $69,256 - $113,221	-9,065 Reduced 46.51%	10,426 $109,000
Q2 2021 Jul 23, 2021	BUY	$8.68 - $27.49 $129,974 - $411,635	14,974 Added 331.5%	19,491 $149,000
Q1 2021 Apr 27, 2021	BUY	$12.0 - $27.64 $54,204 - $124,849	4,517 New	4,517 $69,000

27.1K

150K

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $26.9M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Belvedere Trading LLC with notifications on news.